Infiplus Services
ActiveSummary
For Infiplus Services, at least two filing cycles of the annual accounts are missing. The 2023 annual accounts show equity of €6,607 and a net result of -€7,175. Its solvency ranks better than 30% of 17925 sector peers (fiscal year 2023). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
No current score
Figures too old
The available figures for FY 2023 are too old to assess current financial health.
Filing: At least two filing cycles are missing
Axes, FY 2023 · tick = 2022
Profitability0▼-100
Solvency68▼-18
Growth32
Track record94
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2023Solvency, return and age of the figures
Solvency
43.2%
Return on assets
-46.9%
Age of the figures
33 mo
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 2 filingsPosition against the passed deadline
31-12-2024 close31-07-2025 deadline29-09-2026 today
neutral · Filed after the deadline
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 29-10-2024, 90 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 2 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
90 d late
2022
121 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 2 accounts on average 106 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2023, micro schema
Turnover
€26,569
EBIT margin
-26.7%
Net result
-€7,175
2022 · €12,782
Working capital
-€5,718
2022 · €3,475
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20222023
Turnover€26,569
Operating result€17,887--€7,093
Net result€12,782below the sector's middle half--€7,175below the sector's middle half
EBIT margin-26.7%
Equity€13,782below the sector's middle half-€6,607below the sector's middle half▼ 52.1%
Total assets€22,729below the sector's middle half-€15,290below the sector's middle half▼ 32.7%
Debt€8,946-€8,684▼ 2.9%
Working capital€3,475below the sector's middle half--€5,718below the sector's middle half
Solvency60.6%within the sector's middle half-43.2%within the sector's middle half▼ 17.4pp
Current ratio1.39below the sector's middle half-0.34below the sector's middle half▼ 1.05
Return on assets (ROA)56.2%above the sector's middle half--46.9%below the sector's middle half▼ 103.2pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2023: a loss of €7,093 after €17,887 in 2022.
Balance-sheet composition
2023 in colour, 2022 as the grey bar beneath
Assets €15,290
Fixed assets
€12,324 ▲ 19.6%
Current assets
€2,966 ▼ 76.1%
Equity and liabilities €15,290
Equity
€6,607 ▼ 52.1%
Debt
€8,684 ▼ 2.9%
Debt's share of the balance-sheet total rises from 39.4% to 56.8%. Equity and debt are lower.
Key figures and ratios
EBITDA
-€5,346▼
2022 · €19,531
Cash flow
-€5,428▼
2022 · €14,426
Debt to equity
1.31▲
2022 · 0.65
ROE
-108.6%▼
2022 · 92.7%
Interest coverage
-63.64▼
2022 · 25.22
Debt ≤ 1 year
€8,684▼
2022 · €8,946
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Turnover70 | - | €26,569 | - |
| Goods, raw materials, services and sundry goods60/61 | - | €31,914 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,643 | €1,747 | ▲ 6.3% |
| Other operating charges640/8 | €373 | - | - |
| Gross operating margin9900 | €19,903 | -€5,346 | ▼ 127% |
| Operating profit (loss)9901 | €17,887 | -€7,093 | ▼ 140% |
| Financial income75/76B | - | €2 | - |
| Recurring financial income75 | - | €2 | - |
| Financial charges65/66B | €775 | €84 | ▼ 89.2% |
| Recurring financial charges65 | €775 | €84 | ▼ 89.2% |
| Profit (loss) for the period before taxes9903 | €17,113 | -€7,175 | ▼ 142% |
| Income taxes67/77 | €4,331 | - | - |
| Profit (loss) for the period9904 | €12,782 | -€7,175 | ▼ 156% |
| Profit (loss) for the period to be appropriated9905 | €12,782 | -€7,175 | ▼ 156% |
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €22,729 | €15,290 | ▼ 32.7% |
| Fixed assets21/28 | €10,307 | €12,324 | ▲ 19.6% |
| Tangible fixed assets22/27 | €10,307 | €12,324 | ▲ 19.6% |
| Land and buildings22 | €4,160 | €3,867 | ▼ 7.0% |
| Plant, machinery and equipment23 | €5,430 | €4,090 | ▼ 24.7% |
| Furniture and vehicles24 | €717 | €4,368 | ▲ 509% |
| Current assets29/58 | €12,421 | €2,966 | ▼ 76.1% |
| Amounts receivable within one year40/41 | €2,788 | €2,805 | ▲ 0.6% |
| Other amounts receivable41 | €2,788 | €2,805 | ▲ 0.6% |
| Cash at bank and in hand54/58 | €9,634 | €125 | ▼ 98.7% |
| Deferred charges and accrued income490/1 | - | €36 | - |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €22,729 | €15,290 | ▼ 32.7% |
| Equity10/15 | €13,782 | €6,607 | ▼ 52.1% |
| Contributions10/11 | €5,000 | €5,000 | = |
| Profit (loss) carried forward14 | €8,782 | €1,607 | ▼ 81.7% |
| Amounts payable17/49 | €8,946 | €8,684 | ▼ 2.9% |
| Amounts payable within one year42/48 | €8,946 | €8,684 | ▼ 2.9% |
| Trade debts44 | €616 | €1,412 | ▲ 129% |
| Suppliers440/4 | €616 | €1,412 | ▲ 129% |
| Taxes, remuneration and social security45 | €4,331 | €1,449 | ▼ 66.5% |
| Taxes450/3 | €4,331 | €1,449 | ▼ 66.5% |
| Other amounts payable47/48 | €4,000 | €5,823 | ▲ 45.6% |
| Line | 2022 | 2023 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €12,782 | -€7,175 | ▼ 156% |
| + Depreciation and write-downs630 | €1,643 | €1,747 | ▲ 6.3% |
| Operating cash flow (approximation) | €14,426 | -€5,428 | ▼ 138% |
| Investment in fixed assets (approximation) | - | -€3,765 | - |
| Change in cash | - | -€9,509 | - |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2024
29-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 90 days late
2023
29-11
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 121 days late
NBB filing
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Andenne · 1 establishment unit since 2022
Ground area
2,549 m²
Building footprint
237 m²
2 parcels, Wallonia. Linked by address, not a title deed.
1 establishment unit
BeTherapy
since 20222.327.732.259
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92003H0503/00M000 | Wallonia | 1,438 m² | 1 · 117 m² | - |
| 92003D0004/00Z000 | Wallonia | 1,111 m² | 1 · 120 m² | - |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
FAIRMOUNT SAFEGUARD CORPORATION
BE 0748.635.409
Antwerpen · Eq €10,537
INNA-TAN
BE 1007.989.950
Ganshoren · Eq €37,288
Of 15 companies in sector 86992 we hold annual accounts for 8. 2 are within a factor 10 of this equity. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded04-01-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86992Human health activities
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
77225Rental and leasing activities
86940Nursing and midwifery
86995Nutrition and dietetics services
Contact
E-mail
naim.infiplus@outlook.be
Phone
+32487865749
E-invoicing
Reachable via Peppol
Peppol ID
0208:0779621959
Also
9925:BE0779621959
Registered
10-08-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.